Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis

• Published in: Cancer genetics and cytogenetics 2001-10, Vol.130 (2), p.127-132
• Main Authors: Takeo, Saori, Arai, Hiroshi, Kusano, Noriyoshi, Harada, Tomohiko, Furuya, Tomoko, Kawauchi, Shigeto, Oga, Atsunori, Hirano, Takashi, Yoshida, Tomoharu, Okita, Kiwamu, Sasaki, Kohsuke
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; Carcinoma, Hepatocellular - genetics; Chromosome Aberrations; Female; Gastroenterology. Liver. Pancreas. Abdomen; Genetic Techniques; Humans; Liver Neoplasms - genetics; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Male; Medical sciences; Middle Aged; Nucleic Acid Hybridization - methods; Oligonucleotide Array Sequence Analysis - methods; Oncogenes; Tumors
• ISSN: 0165-4608; 1873-4456
• DOI: 10.1016/S0165-4608(01)00479-4

To identify amplified oncogenes involved in hepatocellular carcinomas (HCC), we applied a genomic DNA microarray spotted with 57 oncogenes to 20 HCCs. Aberrations in DNA copy number also were analyzed by comparative genomic hybridization (CGH) using an aliquot of DNA samples. In 5 of 20 HCCs, only 6 oncogenes (CCND1, FGF3/FGF4, SAS/CDK4, TERC, MET, and MYC) were amplified, whereas in the remaining 15 tumors no oncogenes were amplified. A comparison of DNA microarray and conventional CGH analyses showed that, although 5 of 6 amplified oncogenes shown by microarray were located in chromosomal regions shown by CGH to have increased DNA copy numbers, not all genes located in such chromosomal regions were affected. One of the amplified oncogenes (SAS/CDK4) was found in a chromosomal region that was undetected by CGH. We, therefore, conclude that amplification of the oncogenes examined in this series is not directly implicated in hepatocellular carcinogenesis.